Advertisement
Canada markets open in 6 hours 56 minutes

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7310
    +0.0013 (+0.18%)
     

  • CRUDE OIL

    82.97
    +0.16 (+0.19%)
     

  • Bitcoin CAD

    88,042.05
    -3,132.37 (-3.44%)
     

  • CMC Crypto 200

    1,390.67
    +8.10 (+0.59%)
     

  • GOLD FUTURES

    2,331.80
    -6.60 (-0.28%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,432.00
    -232.50 (-1.32%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6813
    -0.0006 (-0.09%)
     

Cigna (CI) Set to Expand in Telehealth Via MDLIVE Buyout

Zacks Equity Research
·4 min read

Cigna Corp.’s CI unit Evernorth has entered into a definitive agreement to acquire MDLIVE, a privately-held leading 24/7 virtual care delivery platform.

Evernorth is the leading health services portfolio of Cigna that will gain an industry-leading platform for providing virtual care and life-saving services amid the COVID-19 pandemic.

MDLIVE is an appropriate fit in Cigna’s portfolio, given high its customer and provider satisfaction ratings. MDLIVE also has a sizable and forward-thinking client base, class-leading provider network, brand recognition among customers and consumers, along with an experience in medical as well as behavioral health.

The deal is likely to close in second-quarter 2021. Cigna continues to expect to deliver 2021 adjusted earnings per share of at least $20, inclusive of the impact of the MDLIVE acquisition.

ADVERTISEMENT

This move by the company is accurately timed to make the most of the growing opportunities of telehealth services. The COVID-19 pandemic has served as a major catalyst that fueled a rise in the use of telemedicine. This momentum is expected to prevail even after the pandemic ends. Recent surveys show that many Americans plan to continue their virtual healthcare visits even after the current crisis is over.

This growing market certainly presents a tremendous opportunity for companies. Per a report by Fortune Business Insights, the global telehealth market size is expected to reach $559.52 billion in 2027 from $61.40 billion in 2019, at a CAGR of 25.2% during the forecast period. The report mentioned that the cost-effective nature of teleconsultation, reduction in waiting time in outpatient departments and easy access were the factors that led to an increased preference for telehealth services.

Meanwhile, the report mentioned that one of the major driving factors behind the increasing popularity of telehealth services is a rise in healthcare costs across many countries. Notably, Statista estimated that U.S. health expenditure is set to reach $6.2 trillion in 2028.

Such a scenario bodes well for telehealth stocks since the expected rise in healthcare cost is sure to make patients opt for less-expensive teleconsultation services. In fact, per a survey by McKinsey & Company last year, 76% of the survey respondents indicated that they were “highly or moderately likely to use telehealth” going forward.

American Well Corporation AMWL also came out with an IPO in September 2020 to ride the tide of telehealth services. The company, founded in 2006, provides a platform that supports telehealth for around 62,000 healthcare providers, including more than 2,000 hospitals.

Health insurance companies have been turning toward this market. In January, health insurance leader UnitedHealth Group Inc. UNH launched a Virtual Primary Care service to provide virtual health care services to eligible members in 11 states. The same will be rolled out to cover more states.

Last week, another health insurer Humana Inc. HUM inked a deal with Missouri-based Mercy to enhance virtual healthcare for patients.

We believe this deal will be a positive long-term factor for Cigna, which acquired Express Scripts, a pharmacy benefit manager, in 2018 and transformed from just being a health insurer to a healthcare entity, with full focus on growing the health service business.

The stock has gained 15.8% in six months’ time compared with the industry’s rally of 2.5%.

Cigna currently carries a Zacks Rank #2 (Buy).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

+1,500% Growth: One of 2021’s Most Exciting Investment Opportunities

In addition to the stocks you read about above, would you like to see Zacks’ top picks to capitalize on the Internet of Things (IoT)? It is one of the fastest-growing technologies in history, with an estimated 77 billion devices to be connected by 2025. That works out to 127 new devices per second.

Zacks has released a special report to help you capitalize on the Internet of Things’s exponential growth. It reveals 4 under-the-radar stocks that could be some of the most profitable holdings in your portfolio in 2021 and beyond.

Click here to download this report FREE >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report

Humana Inc. (HUM) : Free Stock Analysis Report

Cigna Corporation (CI) : Free Stock Analysis Report

American Well Corporation (AMWL) : Free Stock Analysis Report

To read this article on Zacks.com click here.